Pharma Two B and Hepion Pharmaceuticals Files Registration Statement On Form F-4 Related to Proposed Merger; Proposed Transaction Expected To Close In Q4

Author: Benzinga Newsdesk | September 04, 2024 09:28am

The Registration Statement contains a proxy statement/prospectus in connection with the proposed merger transaction pursuant to the definitive agreement entered into between Pharma Two B and Hepion (the "Merger Agreement", and the proposed transactions contemplated thereby, the "Proposed Transaction"). While the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about Pharma Two B and Hepion and the Proposed Transaction.

Posted In: HEPA